HHS expected to announce link between Tylenol use and autism
The Trump administration is expected to announce a link between Tylenol use among pregnant women and increased risk of autism. Without going into specifics, President Donald Trump over the weekend teased a major announcement regarding autism.
Speaking to Politico on Sunday, two senior Trump administration officials said that the president will deliver a speech on Monday, linking Tylenol use with autism. He’s also expected to tout the cancer drug leucovorin as a potential autism treatment.
The news comes after Trump on Friday told reporters that autism is “totally out of control,” and that his administration may “have a reason why.”
Then, on Saturday, he told a dinner hosted by the conservative American Cornerstone Institute, “We’re going to have an announcement on autism on Monday. I think it’s gonna be a very important announcement. I think it’s gonna be one of the most important things that we will do.”
Trump again teased the announcement during his remarks Sunday at the funeral service for conservative commentator and Turning Point USA founder, Charlie Kirk.
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said in April that his agency would identify the cause of autism by September. At the time, Kennedy pointed to CDC data showing that autism diagnoses have increased from around 1 in 150 children in 2000 to an estimated 1 in 36 today.
Autism was first categorized as a spectrum disorder in the 1994 edition of the Diagnostic and Statistical Manual of Mental Disorders. However, in a revised edition published in 2000, the diagnostic criteria for autism spectrum disorder were widened to include five additional distinct traits, as well as Asperger’s syndrome.
The post HHS expected to announce link between Tylenol use and autism appeared first on Straight Arrow News.
Ella Rae Greene, Editor In Chief
